Unknown

Dataset Information

0

Anaphylactic shock caused by haemocoagulase injection in China.


ABSTRACT: Haemocoagulase injection is a mixture of purified enzymes isolated from the venom of Bothrops atrox, which is used for the prevention and treatment of haemorrhage. It is a relatively safe pharmacological agent that does not require a skin test prior to administration. However, following a literature search, 14 reported cases of anaphylactic shock caused by haemocoagulase injection were identified, including one lethal case in China. Using SDS-PAGE and protein identification, four primary components in haemocoagulase injection were characterized, including one metalloproteinase, which may be a thromboplastin-like enzyme, and two serine proteinases, which may be thrombin-like enzymes. Administering concentrated haemocoagulase injections failed to provoke a positive skin reaction in allergic patients. Basophil activation tests revealed that haemocoagulase injections did not upregulate cluster of differentiation 63 or C-C chemokine receptor type 3 expression. These findings suggest that haemocoagulase injection may cause fetal anaphylaxis. Although it is difficult to determine a clear conclusion without being able to evaluate the patients that underwent haemocoagulase injection-induced shock, it is unlikely that the venomous components of haemocoagulase injection cross-react with common allergens in allergic patients. It is possible that haemocoagulase injection-induced anaphylaxis is caused by its additive components, such as mannitol and succinylated gelatin.

SUBMITTER: Yang H 

PROVIDER: S-EPMC5377524 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Anaphylactic shock caused by haemocoagulase injection in China.

Yang Haiwei H   Yang Liming L   Wang De-Wang DW   Wei Ji-Fu JF   He Shaoheng S  

Experimental and therapeutic medicine 20170214 4


Haemocoagulase injection is a mixture of purified enzymes isolated from the venom of <i>Bothrops atrox</i>, which is used for the prevention and treatment of haemorrhage. It is a relatively safe pharmacological agent that does not require a skin test prior to administration. However, following a literature search, 14 reported cases of anaphylactic shock caused by haemocoagulase injection were identified, including one lethal case in China. Using SDS-PAGE and protein identification, four primary  ...[more]

Similar Datasets

| S-EPMC6291942 | biostudies-literature
| S-EPMC5950693 | biostudies-literature
| S-EPMC2700978 | biostudies-literature
| S-EPMC5266365 | biostudies-literature
| S-EPMC4426654 | biostudies-literature
| S-EPMC4394241 | biostudies-literature
| S-EPMC9449738 | biostudies-literature
| S-EPMC10840016 | biostudies-literature
| S-EPMC6468713 | biostudies-literature
| S-EPMC9228251 | biostudies-literature